RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia
John P. Perentesis(Cincinnati Children's Hospital Medical Center), Leslie L. Robison(St. Jude Children's Research Hospital), William R. Kiffmeyer(University of Minnesota), Eleanor Boyle(Children's Hospital Central California), Ying Shao(St. Jude Children's Research Hospital), J Envall-Fox(University of Minnesota), Xiao‐Ou Shu, Harland N. Sather(University of Southern California), Ravi Bhatia(City Of Hope National Medical Center), P S Gaynon(Children's Hospital of Los Angeles), M. Steinbuch(Oncology Hematology Care)
Cited by 118
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
|Nature reviews. Cancer|2013|864